Atazanavir for HIV Infected Individuals: An Early Access Program

NO_LONGER_AVAILABLE

Conditions studied: HIV Infections

In brief

The purpose of this clinical research study is to provide atazanavir to patients infected with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to control HIV activity within the body and who are unable to create a new treatment regimen using other available anti-HIV drugs, because of either side effects or treatment failure previously taken. The safety of this treatment will also be studied.

Key facts

Study ID
NCT00046345
Run by
Bristol-Myers Squibb
Starts
2002-05-01
Expected to finish
2003-07-01
Last updated by the study team
2011-04-14

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.